Glaxosmithkline has no heart scarring history on

New Post Public Reply Private Reply Replies (2) Message Board
My69z My69z #150146
766
Glaxosmithkline has no heart scarring history on Clinicaltrials. Adding LL for MF to their new mandate, would be economically smart.

Would love to know who & how many 3rd parties are sitting with Cytodyn. This is all just phenominal.

Heart scarring, also known as myocardial fibrosis, is a condition where damaged heart muscle tissue is replaced with non-functional scar tissue. This can occur after a heart attack, heart failure, or other injuries to the heart.
Causes:
Myocardial infarction (heart attack)
Heart failure
Inflammation of the heart (myocarditis)
Infections
Certain medications
Genetic conditions

https://clinicaltrials.gov/search?cond=myocar...smithkline

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insider Purchases: Three Stocks Under $3 Worth Noting

Updated Category News Views 76

Executive Stock Purchases to Watch Recently, the Dow Jones index experienced a minor dip of about 0.2%. One important aspect of stock trading to pay attention to is insider activity—when company executives buy shares, it usually signals their confidence in the company's future. For anyone interested in penny stocks, these transactions can offer valuable insights for...

Continue Reading
Neoss Inc. Unveils Innovative NeoGenix Extraction Allograft

Updated Category News Views 213

Neoss Inc. Expands Biomaterials Portfolio Neoss Inc., a leader in innovative dental implant solutions, has exciting news for dental practitioners. They are proud to introduce the NeoGenix™ Extraction Allograft, a groundbreaking addition to their biomaterials line. This new product is crafted entirely from 100% human allograft bone fiber and bone particulate, aiming to...

Continue Reading
Brookdale Senior Living Shares Occupancy Insights for November

Updated Category News Views 137

Brookdale Senior Living's November 2024 Occupancy Report Brookdale Senior Living Inc. (NYSE: BKD) has officially released its occupancy figures for November 2024, showcasing the latest updates in their performance metrics. This report is crucial for understanding how the company is adapting to the ongoing dynamics of the senior living sector. Understanding the November...

Continue Reading
U.K. Stocks Experience Gains as Market Closes with Positive Signs

Updated Category News Views 102

U.K. Stocks Close Higher Amid Positive Market Trends The financial marketplace in the U.K. saw an uplifting close recently, showcasing a blend of strong performances across various sectors. Notably, the Mining, Household Goods, and General Industrial sectors significantly contributed to the upward momentum, indicating a healthful market environment. Sector Performances...

Continue Reading
Ember and Alfresa Join Forces on Pharma Cold Chain in Japan

Updated Category News Views 17

Strategic Partnerships for Future Growth Every now and then, an alliance pops up that makes investors like me perk up and pay attention. Today, it's Ember LifeSciences teaming up with Alfresa Corporation to shake up the pharmaceutical cold chain logistics scene in Japan. We're talking about a market that's buzzing with potential. This partnership isn't just a handshake...

Continue Reading